MEDBOT-B(02252): The Stock Exchange approves the listing of the company's H-shares for full circulation.

21:35 13/02/2026

Weicai Robotics-B (02252) announced that the company has received approval from the Hong Kong Stock Exchange on February 13, 2026 to list and trade 5,989,800 H shares (convertible H shares) (the total number of non-listed shares that are about to be converted and listed). The conversion and listing will involve a total of 5,989,800 non-listed shares held by two shareholders of the company (participating shareholders), representing approximately 0.5808% of the total number of shares issued by the company as of the date of this announcement.

MEDBOT-B (02252) Announcement: The company has received approval from the Hong Kong Stock Exchange on February 13, 2026 for the listing and trading of 5.98 million H shares (convertible H shares) (the total number of non-listed shares to be converted and listed). The conversion and listing will involve a total of 5.98 million non-listed shares held by two shareholders (participating shareholders) of the company, representing approximately 0.5808% of the total issued shares of the company as of the date of this announcement.

MP CARDIOFLOW-B(02160): Implantable cardiac resynchronization defibrillator entering Innovative Medical Management special review process.

NUR HOLDINGS (00254) issues profit warning, expected that the company's owners' share of the mid-term losses will increase by approximately HK$22 million to HK$25 million compared to the same period last year.

CARRIANNA (00126) plans to sell 100% equity of Profit Share Investments Limited for HKD 45 million.

MP CARDIOFLOW-B(02160): Implantable cardiac resynchronization defibrillator entering Innovative Medical Management special review process.

CARRIANNA (00126) plans to sell 100% equity of Profit Share Investments Limited for HKD 45 million.